Revolutionary Device-Based Therapy Shows Promise for Heart Failure Management in First Human Trials#USA#Irvine#Heart_Failure#Medical_Device#Relief_Cardiovascular
Revolutionary Device-Based Therapy Shows Promise for Heart Failure Management in First Human Trials
Relief Cardiovascular's innovative device-based therapy shows positive results in managing heart failure by reducing venous congestion effectively, enhancing renal flow.
third-news.com
March 3, 2026 at 6:07 PM
Revolutionary Device-Based Therapy Shows Promise for Heart Failure Management in First Human Trials#USA#Irvine#Heart_Failure#Medical_Device#Relief_Cardiovascular
Relief Cardiovascular Welcomes Harry Rowland as New Chairman of the Board#USA#Irvine#Relief_Cardiovascular#Harry_Rowland#Relief_System
Relief Cardiovascular Welcomes Harry Rowland as New Chairman of the Board
Relief Cardiovascular announces Harry Rowland as Chairman. With a strong medical background, he's set to elevate the company's innovative Relief System.
third-news.com
December 18, 2025 at 2:37 PM
Relief Cardiovascular Welcomes Harry Rowland as New Chairman of the Board#USA#Irvine#Relief_Cardiovascular#Harry_Rowland#Relief_System
Revolutionizing Heart Failure Treatment: Relief Cardiovascular's First-in-Human Transcatheter Implant#United_States#Irvine#Heart_Failure#Relief_Cardiovascular#Smart_Implant
Revolutionizing Heart Failure Treatment: Relief Cardiovascular's First-in-Human Transcatheter Implant
Relief Cardiovascular has made history with the first-in-human use of a transcatheter smart implant, aimed at improving heart failure management effectively.
third-news.com
September 30, 2025 at 2:27 PM
Revolutionizing Heart Failure Treatment: Relief Cardiovascular's First-in-Human Transcatheter Implant#United_States#Irvine#Heart_Failure#Relief_Cardiovascular#Smart_Implant
Relief Cardiovascular Secures $12M Series A to Begin Clinical Trials of Groundbreaking Heart Failure Device#Clinical_Trials#Heart_Failure#Relief_Cardiovascular
Relief Cardiovascular Secures $12M Series A to Begin Clinical Trials of Groundbreaking Heart Failure Device
Relief Cardiovascular has successfully closed a $12 million funding round to launch their first-in-human study of the innovative Relief System, aimed at managing heart failure more effectively.
third-news.com
January 8, 2025 at 3:03 PM
Relief Cardiovascular Secures $12M Series A to Begin Clinical Trials of Groundbreaking Heart Failure Device#Clinical_Trials#Heart_Failure#Relief_Cardiovascular